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The Journal of Arthroplasty Vol. 27 No. 6 2012Long-Term Follow-Up of Anatomic Graduated
Component Total Knee Arthroplasty
A 15- to 20-Year Survival Analysis
Maarten R. Huizinga, MD, Reinoud W. Brouwer, MD, PhD, Roel Bisschop, MD,
Hugo C. van der Veen, MD, Inge van den Akker-Scheek, PhD,
and Jos J.A.M. van Raay, MD, PhDAbstract: The aims of this study were to determine survival rate, the clinical performance, and
radiologic results of an Anatomic Graduated Component (AGC) total knee arthroplasty (TKA).
Survival analysis was assessed by analyzing all hospital records of 211AGCTKAs in 177 patients after
15 to 20 years. The survival rate was 87%, with failure defined as revision for any reason including
infection. The main reasons for failure were infection and failure of the metal-backed patellar
component. Clinical evaluation of 30 patients (33 TKAs) and questionnaires of 20 patients (23 TKAs)
were taken, showing moderate to good results (mean Knee Society Score, 51; mean Western
Ontario and McMaster Universities Osteoarthritis index, 82; mean University of California Los
Angeles score, 4). Radiologic evaluation of 13 TKAs in 12 patients showed that none was suspect for
loosening. Three knees showed significantmedialwear but no clinical complaints. In conclusion, this
is one of the first studies showing that AGC total knee prosthesis has good results 15 to 20 years after
surgery. Keywords: AGC, survival, revision, knee, arthroplasty.
© 2012 Elsevier Inc. All rights reserved.Total knee arthroplasty (TKA) is a highly effective
procedure that provides reliable relief from pain,
improved physical function, and a high level of patient
satisfaction in patients with advanced knee osteoarthritis
[1]. Long-term follow-up studies are scarce, especially of
young patients. Anatomic Graduated Component (AGC;
Biomet, Inc, Warsaw, Ind) TKA is a commonly used
implant in the treatment of advanced osteoarthritis and
rheumatoid arthritis. Research on this prosthesis and its
survival and functional outcome in studies with up to 15
years of follow-up has been conducted [2-8]. The aims
of this study were to determine survival rate, clinical
performance, and radiologic results 15 to 20 years after
an AGC TKA.he Department of Orthopedic Surgery, Martini Hospital Groningen,
enplein 1, 9700 RM Groningen, the Netherlands.
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This is a retrospective cohort study. All patients who
received a TKA between 1987 and 1992 at Martini
Hospital in Groningen, the Netherlands, were included.
The implant used was the AGC TKA (Biomet). This is a
cemented posterior-cruciate ligament-retaining prosthe-
sis with a monoblock tibial component and ﬁxed
polyethylene bearing. The concept was introduced in
1983, and from 1986 onward, the design has essentially
remained unchanged [8]. A metal-backed patella was
used until 1990; since then, a polyethylene-pegged
patellar button has been used because of a high
incidence of aseptic loosening of the metal-backed
patellar button observed in the study by Ritter et al [9].
Outcomes
The primary outcome measure was survival of the
TKA. Failurewas deﬁned as having had revision surgery.
Revision was deﬁned as removal or exchange of a
prosthetic component for any reason including infec-
tion. Reasons for revision were assessed. Secondary
outcome measures included the functional scores of the
Knee Society Score (KSS) [10] as a physician-based
outcome measure, the Western Ontario and McMaster
Universities Osteoarthritis index (WOMAC) [11,12] as a
disease-speciﬁc patient-reported outcome measure, and0
Long-Term Follow-Up of Anatomic Graduated Component TKA  Huizinga et al 1191the Short-Form 36 score [13] to determine generic
health-related quality of life. All scores range from 0 to
100, with 100 representing the best result. The
University of California Los Angeles (UCLA) score was
added to determine physical activity status on a scale
ranging from 0 (wholly inactive) to 10 (regularly
participates in impact sports) [14].Radiologic Investigation
X-rays were taken in a standing position in both
directions. The Roentgenographic Evaluation System
was used to quantify the number of radiolucent lines
representing loosening of the interface between com-
ponent with cement and bone [15]. The interface of
each component is divided into a number of zones. The
scoring system for each of the components is determined
by measuring the width of the radiolucent lines for each
zone in millimeters. Four or less millimeters of radiolu-
cent lines is not signiﬁcant, 5 to 9 mm should be
followed closely for progression, and 10 mm or more
signiﬁes possible or impending failure of the component.Fig. 1. Patient ﬂowchart.Study Procedure
Hospital records were reviewed, and demographic
data such as age at surgery, sex, indication for surgery,
treated side, complications, and whether or not revision
surgery had taken place were noted in a database. Of the
patients who had died at the time the study was
conducted, date of death was noted as well as the
other demographic data. If no problems with the TKA
were described at the last visit, we presumed that there
were none at the time of death because the arthroplasty
had not been revised.
All living patients were invited to participate in the
study. Those who wanted to participate visited the
outpatient clinic. Whenever it was not possible to
come to the outpatient clinic (mainly because of
transportation problems), these patients were visited
by the examiner at their homes. Whenever patients
did not want to come to the clinic or be visited at their
homes, they were interviewed by telephone. Those
patients who visited the outpatient clinic underwent a
physical examination, and the KSS was completed.
During this visit, the WOMAC, Short-form 36, and
UCLA questionnaires were ﬁlled out by the patients
and their families, and a standing anteroposterior and
lateral x-ray was taken. Patients visited at home were
administered the 4 questionnaires and given a physical
examination but had no x-rays taken. For patients
who were interviewed by telephone, the KSS tele-
phone score was completed. This telephone interview
simulates the KSS [8].
The study was approved by the local medical ethical
committee, and all participating patients ﬁlled out an
informed consent form.Statistical Analysis
Survival data were determined for implant survival
[16]. A life table was constructed for survival analysis of
the implant using the technique described by Murray et
al [17]. To construct this life table, the number of TKAs
being followed and the number of failures were
determined for each year. The ﬁrst year starts with the
total number in the study; in subsequent years, this
number fall away gradually to zero as a result of death or
revision surgery (failure). For each successive year, the
failure rate was calculated from the number of failures
and the “number at risk.” Failurewas deﬁned as revision
of the prosthesis for any cause. The life table method is
advantageous because the failure rate is determined for
each successive year, and details for each year about the
number of TKAs followed, the number of failures, and
the number of deceased are provided. By contrast, the
product-limit method (Kaplan and Meier) recalculates
the survival rate each time a failure occurs and does not
provide details for each successive year.
The inﬂuence of sex, indication being primary osteo-
arthritis or other, age at the time of operation, type of
patellar button (metal-backed or polyethylene), and
bilaterality were evaluated in a multivariate logistic
regression analysis. Means and standard deviations were
calculated for the total scores of the WOMAC, SF-36,
UCLA, and KSS questionnaires.
Results
The cohort (Fig. 1, ﬂowchart) consists of 227 TKAs in
192 patients who underwent a primary AGC TKA











0-1 211 0 211 0 1.00
1-2 211 4 209 1 1.00
2-3 206 6 203 3 0.98
3-4 197 7 193.5 3 0.97
4-5 187 7 183.5 0 0.97
5-6 180 7 176.5 2 0.95
6-7 171 13 164.5 0 0.95
7-8 158 16 150 0 0.95
8-9 142 9 137.5 1 0.95
9-10 132 8 128 0 0.95
10-11 124 12 118 0 0.95
11-12 112 12 106 3 0.92
12-13 97 9 92.5 1 0.91
13-14 87 10 82 1 0.90
14-15 76 10 71 1 0.89
15-16 65 18 56 1 0.87
16-17 46 17 37.5 0 0.87
17-18 29 11 23.5 0 0.87
18-19 18 8 14 0 0.87
19-20 10 5 7.5 0 0.87
20-21 5 4 3 0 0.87
21-22 1 1 0.5 0 0.87
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(16 TKAs) who had died were lost, and these patients
were excluded (6.6%). The study population, therefore,
consisted of 211 knee arthroplasties in 177 patients.
There were 34 patients with bilateral TKA. The
average (SD) age of the patients was 72.6 (8.9) years,
with a range of 21 to 91 years at the time of surgery.
Twenty-four knee arthroplasties were done in male
patients (11%) and 187 in female patients (89%).
Most indications were primary osteoarthritis (81.5%)
and rheumatoid arthritis (14.2%); other indications
were posttraumatic arthritis (1.9%), secondary osteo-
arthritis after tuberculous arthritis (1.0%), rachitis
(0.5%) or septic arthritis (0.5%), and avascular
necrosis (0.5%). All 3 components were cemented,
and in all but 3 (after prior patellectomy), the patella
was resurfaced. Most of the patellae (148; 71%) were
resurfaced with a polyethylene dome patella; 60
(29%) were resurfaced with a metal-backed patella.
At the time this study was conducted, 130 patients
(74%) with 157 TKAs had died, leaving 47 patients with
54 knee arthroplasties available for clinical analysis.
Primary Outcome
Survival analysis in this series showed a survival rate
of 87% at 20 years (Fig. 2; Table 1). Of the 211 knee
arthroplasties, 17 were revised (8.1%) for the follow-
ing reasons: 5 TKAs were revised because of infection;
in 8 TKAs, the patella was removed because of aseptic
loosening; in 1 knee, the patella was removed after a
patellar fracture caused by loosening of the patellar
component; 2 TKAs were revised because of aseptic
loosening of the tibial plateau; and 1 knee was revised
because of aseptic loosening of the tibial plateau asFig. 2. Survival analysis cwell as the patella. In 7 of the 8 knees that were
reoperated because of aseptic loosening of the patella,
this involved a metal-backed patella, which failed at an
average of 6.1 years. No revisions had taken place
because of aseptic loosening of the femoral compo-
nent. Overall, revision surgery took place at an average
of 7.5 years (range, 1-15 years) after a primary
operation. No revision was done because of extensive
wear of the polyethylene.urve of the AGC TKA.
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that indication (primary or secondary osteoarthritis),
sex, age at operation, type of patellar component
(metal-backed or polyethylene), and bilaterality were
not signiﬁcant risk factors for failure; all 95%
conﬁdence intervals of the odds ratios included 1 risk
factor (Table 2).
Secondary Outcomes
At the time of the investigation, 47 patients (54
TKAs) were still alive (Fig. 1). Seven patients with 7
TKAs had dementia and were, therefore, excluded.
Five patients with 7 TKAs did not want to participate.
Seven TKAs in 5 patients had been revised. This
leaves 30 patients with 33 TKAs for analysis. Twelve
patients (13 TKAs) visited the outpatient clinic,
8 patients (10 TKAs) were visited at home by the
examiner, and 10 patients (10 TKAs) were inter-
viewed by telephone.
The KSS was scored in 30 patients (33 TKAs). The
mean (SD) KSS was 51 (20) points. Of the 20 patients
(23 TKAs) who visited the outpatient clinic or were
visited at home, the mean (SD) function score was
25.9 (31.5), the mean (SD) knee score (physical
examination) was 77.3 (16.4), and the mean (SD)
ﬂexion of the knees was 102° (13.4 °). The WOMAC,
UCLA, and SF-36 were scored in 20 patients (23
TKAs). The mean (SD) WOMAC score was 82 (16)
(pain, 86.6; stiffness, 91.5; function, 64.4). The mean
(SD) UCLA score was 3.9 (1.9), representing doing
mild activities regularly. The mean (SD) SF-36 score
on physical health was 60 (21) of 100.
Radiographs of the 12 patients (13 TKAs) who visited
the outpatient clinic were taken. In all but 2 knee
prostheses, radiolucent lines were observed at the
prosthetic interface. No prostheses had clinical symp-
toms; therefore, none of the components were suspected
to be loose at radiologic evaluation. Three tibial
components had signiﬁcant polywear (N4 mm) at the







Being male* 0.93 0.19 4.55
Age at operation (y) 0.97 0.92 1.02
Indication not being primary
osteoarthritis †
1.31 0.36 4.79
Metal-backed patella ‡ 2.30 0.78 6.72
Bilaterality § 1.04 0.33 3.25
* Female as reference.
† Primary osteoarthritis as reference.
‡ Polyethylene patella as reference.
§ Unilaterality as reference.Discussion
The AGC prosthesis that we used between 1987 and
1992 is a posterior-cruciate ligament-retaining total
condylar TKA. The design of this prosthesis has
essentially remained an unchanged design since 1986.
We found an 87% survival after 15 to 20 years.
Failure was deﬁned as removal or exchange of any
prosthetic component for any cause including infection.
This deﬁnition is simple, reproducible, and objective and
is also used in other studies [3,7,8,18-20]. Not all
survival studies include infection in the deﬁnition of
failure, though [2,6,21,22], which may explain different
outcomes on survival in multiple studies.
Main reasons for failure in this series were infection
and aseptic loosening of the metal-backed patellar
component; therefore, its use was suspended in 1991.
Emerson et al [2] also found a higher number of revisions
in the metal-backed patellar group at an average of 6.7
years after surgery. Stulberg et al [23] analyzed revisions
that appeared at an average of 14 months. In our study,
themetal-backed patella failed at an average of 6.1 years,
which is in line with other studies. Furthermore, in our
study, there were 2 revisions because of failure of the
tibial component, 1 because of failure of the tibial and
patellar components, and no revisions because of failure
of the femoral component; no patients needed revision
surgery because of extensive wear of the polyethylene
(no instability and no loosening). Other studies have also
found that the AGC prosthesis has proved to show no
clinical symptoms of signiﬁcant wear [2,24]. The
Swedish Knee Arthroplasty Register shows the AGC to
be one of the least revised TKA [25].
In comparison with prior studies on the ACG TKA,
our study, together with Ritter [26], is unique because
of its long-term follow-up. Ritter describes a survival
rate of 97.8% after 20 years and attributes the success
of the AGC implant to its relatively unconstrained
articular geometry and the durability of a nonmodular
metal-backed tibial component with compression-
molded polyethylene. Ritter's higher survival rate
may be attributed to his correction for preoperative
valgus deformity, which seemed to have a signiﬁcant
inﬂuence on survival. Because these preoperative data
were not available to us, we could not correct for this
to see if this indeed explains the difference in survival
between the 2 studies.
There are several other survival studies of the AGC
TKA with shorter follow-up. Worland et al [8] report
96.9% survival at 14 years in a study group of 562 TKAs
with revision for any reason as the end point. Emerson
et al [2] report survival of 95% at 11.4 years in 62 TKAs
with revision for any reason except sepsis. They only
included the living patients. Ritter et al [22] report 98%
survival at 10 years with revision for any reason except
sepsis. In a different study, Ritter et al [6] report survival
of 98% at 15 years in 4583 TKAs with revision for any
1194 The Journal of Arthroplasty Vol. 27 No. 6 June 2012reason except sepsis. Himanen et al [3] report 95%
survival at 10 years (mean follow-up, b5 years) in a
Finnish population of 8467 TKAs. Schrder et al [7]
report 97% survival at 10 years in 114 TKAs with
revision for any reason as the end point. Compared with
these studies, our results of survival are a little lower
after longer follow-up but comparable after a likewise
follow-up period; just like Emerson et al [2], we also
report survival of 95% after 11 years.
In a Norwegian follow-up study of TKAs, the AGC had
a survival rate of 97% at 5-year follow-up, comparable
with 5 other cemented tricompartment total knee
prostheses [5]. This is the same as in our study: at 5
years, we also have a survival rate of 97%.
There are few studies of other designs of total knee
prostheses with a follow-up of more than 15 years.
Rodricks et al [19] report 91.5% survival of 63 press-ﬁt
condylar total knee arthroplasties at 14 to 17 years
(average, 15.8 years). Goldberg and Kraay [18] report
87% survival of 124 Miller Galante I (Zimmer, Warsaw,
Ind) total knee arthroplasties at 14 to 17 years. Ma et al
[21] report 91.9% survival of 64 total condylar knee
arthroplasties at 20 years. Van Loon et al [20] report 87%
survival of 77 GSB-II (Sulzer Medica, Winterthur,
Switzerland) total knee arthroplasties at 15 years.
Overall, these data seem comparable with our results,
yet comparison is difﬁcult because of different deﬁnitions
of failure. Some studies include infections as failures, and
others exclude infections because they onlywant to asses
the mechanical aspects of the prosthesis.
We determined pain and functional scores as a way to
investigate whether the prosthesis not only survived but
is also performing well. The results show that patients
have little pain (WOMAC pain score, 86.6). Physical
examination scores are also high (knee score KSS, 77.3;
mean ﬂexion, 102°). Functional scores (WOMAC
function score, 64.4; UCLA, 3.9) show that patients
have some limitations during activities of daily living and
are mildly active regularly. This leads to the conclusion
that the prosthesis performs generally well, but patients
are only mildly active, which can be due to other factors
unrelated to their prosthesis.
This is a 15- to 20-year survival study in a group of
patients whose average (SD) age at the time of surgery
was 72.6 (8.9) years. Many patients (74%) died before
this study was conducted. If the last visit to our clinic was
uncomplicated, we assumed that there were no prob-
lems with the prosthesis until the patient died. This is a
limitation of our study and may have led to an
overestimation of the survival. We had a low rate of
lost to follow-up; in this study, we could not ﬁnd any
information beyond 2 months after surgery and, for
6.6% of the patients, the fact that the patient had died.
These patients were excluded from our study.
In conclusion, the current study reveals that the AGC
posterior-cruciate ligament-retaining TKA has longevitywith a survivorship of 87% at 20 years, with failure
deﬁned as revision for any reason including sepsis. This
implant system has remained essentially unchanged
since 1986. Main reasons for failure were infection and
failure of the metal-backed patellar component. This
component is no longer used. Polyethylene wear seems
not to play a signiﬁcant role in failure, in contrast with
total hip arthroplasty, and no femoral components were
revised for aseptic loosening. Long-term follow-up
studies of the modern-type implants have to show
survival rates after a follow-up period of at least 10 years
and must be compared with the older-type TKAs,
preferably in randomized trials.
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